Urges Hawaii State Director of Health to allow sale of nebulized budesonide without prescription for COVID-19 treatment.

This bill urges the Hawaii State Director of Health to issue a statewide order permitting the sale and purchase of nebulized budesonide without a prescription or consultation with a healthcare provider. The bill cites studies and trials demonstrating the effectiveness of nebulized budesonide in treating COVID-19, reducing the risk of pneumonia, and improving patient outcomes. It also references recommendations from various health departments and organizations worldwide, including the U.K., Australia, and India, that support the use of budesonide for COVID-19 treatment.

Urges Hawaii State Director of Health to allow sale of nebulized budesonide without prescription for COVID-19 treatment.

This bill urges the Hawaii State Director of Health to issue a statewide order permitting the sale and purchase of nebulized budesonide without a prescription or consultation with a healthcare provider. The bill cites studies and trials demonstrating the effectiveness of nebulized budesonide in treating COVID-19, reducing the risk of pneumonia, and improving patient outcomes. It also references recommendations from various health departments and organizations worldwide, including the U.K., Australia, and India, that support the use of budesonide for COVID-19 treatment.